BioSpace News Archive

Enanta Pharmaceuticals, Inc., a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, announced that data from Enanta’s wholly-owned development programs for non-alcoholic steatohepatitis and hepatitis B virus will be presented at the European Association for the Study of the Liver Digital International Liver Congress™ 2020.

Topcon Healthcare, a leading provider of medical devices and software solutions for the global eye care community, announced that it has launched its new Aladdin-M instrument to the US market.

Sun BioPharma, Inc. (OTCQB:SNBP Nasdaq:SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with pancreatic cancer, today announced the pricing of an underwritten public offering of 2,545,454 shares of common stock and the same number of warrants to purchase shares of common stock for a price to the public of $4.125 per share and warrant. Gross proceeds to the company are expected to

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that Chief Executive Officer, Robb Knie, is scheduled to present at the following investor conferences in September: T

The TARGIT Collaborative Group (TCG) is pleased to announce publication of the long-term results of the Targeted Intraoperative Radiotherapy Trial (TARGIT-A Trial) comparing partial breast single fraction targeted intraoperative radiotherapy (TARGIT-IORT) to 3-6 week post-operative whole breast radiotherapy, demonstrating equivalent long-term outcomes between the two treatments. The results of the trial were published

Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing transformative therapies to cure blindness diseases, today announced it will present at the LD 500 Virtual Investor Conference on Friday, September 4 at 11 a.m. ET. Sanjay Subramanian, Chief Financial Officer, will present virtually to an online audience highlighting Ocugen’s breakthrough gene therapy platform as well as its

Golden State Dermatology is pleased to announce Kathy Fang, M.D., Ph.D. and her team have joined Golden State Dermatology.

Numotion, the nation’s leading provider of Complex Rehab Technology (CRT), has expanded into Sioux Falls, South Dakota , with the acquisition of Northland Rehab Supply. Northland was founded in 2000 and over a 20 year period, has been dedicated to serving the mobility needs of customers across South Dakota , Nebraska , Iowa a

Braingrid Limited is pleased to announce the appointment of Mr. Andrew Parks as the Company’s Interim Chief Executive Officer, who will lead a review of the Company’s business and potential strategic alternatives.

Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the U.S. Food and Drug Administration (“FDA”) has informed the Company that it needs additional time to complete its review of TLANDO’s New Drug Application (“NDA”) and is committed to taking ac